The U.K.’s Department for International Development (DfID) plans to invest £138 million ($214.5 million) over the next five years “with nine public-private partnerships to support development of drugs, vaccines, insecticides, diagnostic tools and microbicides, all to prevent, diagnose or treat disease,” This Is Guernsey reports (8/22). “Diseases to be targeted…

A blog post by the WHO’s Regional Office for Europe discusses efforts to improve maternal and child health in Tajikistan, writing, “During the last five years WHO has assisted Tajikistan in introducing ‘Beyond the numbers’ approaches that go beyond counting maternal deaths or severe morbidity cases to developing an understanding…

“Europe is facing a multi-billion-euro time bomb of rising costs to control tuberculosis (TB) as drug-resistant forms of the lung disease spread, a pioneering study found,” Reuters reports. “Often thought of as a disease of the past or one restricted to marginalized communities, TB is already inflicting annual direct costs…

AIDS-related deaths “in Eastern Europe and the former Soviet Union have soared in the last decade while the E.U. continues to put the brunt of its funding for treatment and prevention in developing nations, according to experts who say this is creating a potential health timebomb on the E.U.’s eastern frontier,” EurActiv reports. “Efforts over the…

The Wall Street Journal examines a recent outbreak of measles in Wales, discussing the backlash in the U.S. and U.K. against immunizations following allegations that vaccines were linked to autism — a theory which has since been disproved — as well as the implications for global health. The outbreak, which has…

“One third of the world’s population is infected with Mycobacterium tuberculosis, the bacterium that causes TB, and one tenth of these people will become sick from the illness during their lifetime,” WHO Regional Director for Europe Zsuzsanna Jakab writes in the Huffington Post’s “The Big Push” blog. “Today we are…

The Guardian examines Evidence 4 Action (E4A), an initiative recently launched in Sierra Leone with support from the U.K. Department for International Development (DfID) that aims “to empower local communities to force health care up the political agenda by giving them the evidence they need to fuel arguments for higher…

“A series beginning in today’s Lancet seeks to provide a global perspective on kidney disease,” the journal reports in an editorial highlighting several articles on renal issues. “The prevalence of kidney disease is likely to be underestimated,” the editorial notes. The current issue of The Lancet, No. 9887, also includes…

“At a Brussels event on Tuesday, Andris Piebalgs, the European commissioner for development, presented recommendations by a high-level U.N. advisory panel on post-2015 global development to an audience of researchers, aid officials and representatives from civil society and E.U. member states,” Devex reports, and provides a transcript of an interview…

As part of an ongoing series on tuberculosis (TB), NPR’s “Shots” blog and “All Things Considered” program examine an initiative working to treat drug-resistant TB in Siberia, noting, “In parts of Siberia, nearly 30 percent of all tuberculosis cases aren’t treatable by two of the most potent medications, the [WHO]…